Borderline resectable pancreatic cancer
Conditions
Interventions
Neoadjuvant chemotherapy using GEM and nabPTX
Sponsors
Department of gastroenterological surgery, Yokohama city university graduate school of medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Cases diagnosed BRPC 2.Cases which chemotherapy and radiation were not performed 3.Over twenty years of age 4.Cases whose performance status at ECOG is from 0 to 1 5.Good organ function Neutrophil more than 1500, Platelet more than 100000, Hb more than 9, AST/ALT less than 7.5, T-Bil less than 2.0, Cr less than 1.5
Exclusion criteria
Exclusion criteria: 1.Medical history of severe drug allergy 2.Cases which have severe complication 3.A pregnant woman, a woman who is probably pregnant, and a man who expect patner's pregnancy 4.Cases which have active infection with a fever over 38 degrees 5.Peripheral neuropathy more than grade 2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Response rate | — |
Countries
Japan
Contacts
Public ContactKentaro Miyake
Yokohama city university graduate school of medicine Department of gastroenterological surgery
Outcome results
None listed